CHAO CHENG to Breast Neoplasms
This is a "connection" page, showing publications CHAO CHENG has written about Breast Neoplasms.
Connection Strength
3.405
-
Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer. Sci Rep. 2017 Nov 16; 7(1):15742.
Score: 0.252
-
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients. BMC Cancer. 2017 05 02; 17(1):306.
Score: 0.243
-
Contextual Refinement of Regulatory Targets Reveals Effects on Breast Cancer Prognosis of the Regulome. PLoS Comput Biol. 2017 01; 13(1):e1005340.
Score: 0.238
-
Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis. Oncotarget. 2016 Dec 20; 7(51):84142-84154.
Score: 0.237
-
Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer. Genome Med. 2016 10 27; 8(1):114.
Score: 0.235
-
Adaptive immunity programmes in breast cancer. Immunology. 2017 Jan; 150(1):25-34.
Score: 0.233
-
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles. Nat Commun. 2016 Jan 04; 7:10248.
Score: 0.222
-
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer. PLoS Comput Biol. 2015 May; 11(5):e1004269.
Score: 0.212
-
Integrative analysis of survival-associated gene sets in breast cancer. BMC Med Genomics. 2015 Mar 12; 8:11.
Score: 0.209
-
E2F4 regulatory program predicts patient survival prognosis in breast cancer. Breast Cancer Res. 2014 Dec 02; 16(6):486.
Score: 0.206
-
Effect of estrogen receptor a binding on functional DNA methylation in breast cancer. Epigenetics. 2014 Apr; 9(4):523-32.
Score: 0.193
-
REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer. BMC Genomics. 2013 Jul 26; 14:504.
Score: 0.187
-
mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol. 2009; 10(9):R90.
Score: 0.143
-
Systematic identification of transcription factors associated with patient survival in cancers. BMC Genomics. 2009 May 15; 10:225.
Score: 0.140
-
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies. Cell Rep. 2019 12 10; 29(11):3405-3420.e5.
Score: 0.073
-
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. Clin Cancer Res. 2020 01 01; 26(1):159-170.
Score: 0.072
-
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier. Breast Cancer Res. 2019 01 25; 21(1):14.
Score: 0.069
-
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J. 2019 02; 33(2):1644-1657.
Score: 0.067
-
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med. 2018 03 05; 215(3):895-910.
Score: 0.064
-
Unsupervised feature construction and knowledge extraction from genome-wide assays of breast cancer with denoising autoencoders. Pac Symp Biocomput. 2015; 132-43.
Score: 0.052
-
Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. Epigenetics. 2014 Feb; 9(2):268-75.
Score: 0.048
-
A comprehensive nuclear receptor network for breast cancer cells. Cell Rep. 2013 Feb 21; 3(2):538-51.
Score: 0.011